Evidence map›Paper›PMID 41041540›Full record

ArticleResearch square2025

Imaging-genetics-based dementia risk prediction using deep survival neural networks in the Rotterdam Study.

Jing Yu, Mathijs T Rosbergen, Frank J Wolters, Esther E Bron, Meike W Vernooij, M Arfan Ikram, Gennady V Roshchupkin

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jing YuErasmus MC University Medical Center.
Mathijs T RosbergenErasmus MC University Medical Center.
Frank J WoltersErasmus MC University Medical Center.
Esther E BronErasmus MC University Medical Center.
Meike W VernooijErasmus MC University Medical Center.
M Arfan IkramErasmus MC University Medical Center.
Gennady V RoshchupkinErasmus MC University Medical Center.

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
NIA NIH HHS U19 AG024904
6 · The paper itself

Abstract

Accurate dementia risk prediction is challenging, and may be facilitated by better use of imaging and genetic data, including their complex interactions. We explored using deep survival neural networks to integrate these multi-modal, high-dimensional data. We included 3521 Rotterdam Study participants, 6340 magnetic resonance imaging (MRI) scans, with follow-up clinical diagnosis for dementia, and used 504 samples from Alzheimer's Disease Neuroimaging Initiative (ADNI) as an external validation. Genetic data included APOE-ε4 status and 76 additional SNPs. We developed models combining Convolutional Neural Networks (CNN) and Cox Proportional Hazards (CPH) models and provided post-hoc explanations. Our models outperformed CPH models including age, sex, and genetic inputs in both Rotterdam Study and ADNI by C-index of 0.88/0.63 V.S. 0.85/0.58, p-value of 0.02/0.002. Although their performance did not surpass CPH models also included MRI markers (0.89/0.66), additional predictability was obtained in age-stratified prediction in ADNI. Incorporating CNN image features in CPH models further increased performance to highest C-index of 0.90/0.69. Age and image had the highest importance in prediction, with age, image and genetic features showing the strongest interactions. Our approach indicates that imaging and genetic data can be feasibly integrated for dementia risk prediction, with informative extraction, reliable explanations and potential predictive gains.

Indexed as

brain MRIcohort studydeep learningdementia risk predictiongeneticssurvival analysis

Identifiers

PMID41041540
PMCPMC12486081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.